熱門資訊> 正文
Vivos Therapeutics宣布以430万美元注册直接发行普通股
2024-09-19 19:53
- Vivos Therapeutics (NASDAQ:VVOS) has entered into agreement for direct offering of an aggregate of 1.36M common shares at $3.15 per share for gross proceeds of ~$4.3M
- Closing date is September 20.
- The net proceeds will be used for the offering for working capital and general corporate purposes.
- VVOS -21.5% premarket to $3.24
- Source: Press Release
More on Vivos Therapeutics
- Vivos Therapeutics, Inc. (VVOS) Q2 2024 Earnings Call Transcript
- Vivos surges on FDA nod for pediatric sleep apnea device
- Vivos gains as pilot program validates new market model
- Seeking Alpha’s Quant Rating on Vivos Therapeutics
- Historical earnings data for Vivos Therapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
